727 Topline Safety and Efficacy Update of SUPLEXA-101, a First-in-human, Single Agent Study of SUPLEXA Therapeutic Cells in 28 Patients with Metastatic Solid Tumours
Journal for ImmunoTherapy of Cancer(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined